S&P 500
(0.05%) 5 471.97 points
Dow Jones
(0.06%) 39 138 points
Nasdaq
(0.29%) 17 768 points
Oil
(-0.22%) $80.65
Gas
(-5.04%) $2.62
Gold
(-0.89%) $2 310.10
Silver
(-0.37%) $28.76
Platinum
(3.07%) $1 016.70
USD/EUR
(0.34%) $0.936
USD/NOK
(0.74%) $10.68
USD/GBP
(0.50%) $0.792
USD/RUB
(-0.28%) $87.25

Sanntidsoppdatering for Alaunos Therapeutics, [TCRT]

Børs: NASDAQ Sektor: Healthcare Industri: Biotechnology
Sist oppdatert26 jun 2024 @ 21:49

4.49% $ 0.692

Live Chart Being Loaded With Signals

Commentary (26 jun 2024 @ 21:49):
Our systems believe the stock currently is undervalued by 0.35% compare to its pairs and should correct upwards.

Alaunos Therapeutics, Inc., a clinical-stage oncology-focused cell therapy company, develops adoptive TCR engineered T-cell therapies. It develops TCR Library, which is in Phase I/II clinical trial for ten TCRs reactive to mutated KRAS, TP53, and EGFR from its TCR library for the treatment of non-small cell lung, colorectal, endometrial, pancreatic, ovarian, and bile duct cancers; hunTR, a human neoantigen T-cell receptor platform; and mbIL-15 to treat solid tumors...

Stats
Dagens volum 18 141
Gjennomsnittsvolum 45 500
Markedsverdi 11.08M
EPS $-0.110 ( Q1 | 2024-05-15 )
Neste inntjeningsdato ( $0 ) 2024-08-12
Last Dividend $0 ( N/A )
Next Dividend $0 ( N/A )
P/E -0.0200
(Sector) 42.63
(Industry) 24.32
ATR14 $0.0140 (2.02%)
AADI -5.88%
ABCL 1.28%
ABCM 0.04%
ABEO -3.08%
ABIO -0.30%
ABOS 1.64%
ABSI 3.40%
ABUS -1.15%
ABVX -3.00%
ACAD -0.45%
ACER -17.95%
ACET -9.18%
ACGN 1.29%
ACHL -1.70%
ACHV 2.59%
ACIU -0.50%
ACLX -0.56%
ACRV -4.29%
ACST -3.58%
ACXP 3.69%
ADAG 7.14%
ADAP -3.98%
ADGI 0.87%
ADIL -2.66%
ADMA -1.23%
ADPT 0.44%
ADTX -3.47%
ADVM 1.16%
ADXN -1.60%
AEON -4.67%
AEZS -2.49%
AFMD -3.15%
AGEN -4.03%
AGIO -2.48%
AGLE 6.66%
AGTC 0.00%
AIKI 0.85%
AIMDW -13.88%
AKBA 8.20%
AKRO -2.32%
AKTX -5.23%
AKUS 0.00%
ALBO 0.00%
ALDX -2.10%
ALEC -0.80%
ALGS -0.37%
ALKS 1.86%
ALLK -11.39%
ALLO -2.50%
ALLR -3.66%
ALNA 3.16%
ALNY 2.08%
ALPN 0.02%
ALPX 0.00%
ALRN -2.18%
ALT -15.31%
ALVR -0.55%
ALXN 0.00%
ALXO -10.59%
ALZN 5.10%
AMRN -4.57%
AMTI -3.13%
ANAB 1.45%
ANEB 7.95%
ANGN 0.00%
ANIX -3.64%
ANL -0.14%
ANNX 3.83%
ANPC -3.15%
APGE 2.00%
APGN 8.48%
APGNW 30.65%
APLM -3.25%
APLS 0.10%
APLT 1.35%
APM 1.47%
APOP 0.38%
APRE -3.13%
APTO 0.62%
APTX 3.17%
APVO 3.21%
ARAV -13.39%
ARCT -6.81%
ARDS -12.13%
ARDX 2.24%
ARGX -0.79%
ARNA 0.00%
ARPO -0.90%
ARQT -3.59%
ARTL -2.50%
ARTLW 0.00%
ARVN 7.24%
ARWR -2.31%
ASLN -2.45%
ASMB -5.55%
ASND -2.24%
ATAI -3.69%
ATHA 7.76%
ATHE 0.08%
ATHX -33.50%
ATNF 2.18%
ATOS 4.83%
ATRA -6.30%
ATXI 1.09%
ATXS -0.50%
AUPH -0.81%
AURA 4.85%
AUTL -3.30%
AVBP -1.68%
AVEO 0.00%
AVIR -1.75%
AVRO -1.41%
AVTE -0.35%
AVTX -4.26%
AVXL -5.80%
AXLA 0.00%
AXSM -1.35%
AYLA 0.00%
AZRX 2.07%
BBI 2.17%
BBIO 1.20%
BCAB -6.86%
BCDA -0.85%
BCDAW -46.41%
BCEL 0.00%
BCLI 3.09%
BCRX 1.73%
BCTX 13.26%
BCTXW 1.97%
BCYC 1.10%
BDRX -5.56%
BDTX 0.21%
BEAM 2.52%
BFRA -2.91%
BGNE -2.89%
BIOR -3.83%
BIVI 2.38%
BLCM -6.68%
BLI -5.88%
BLPH 0.00%
BLRX -0.89%
BLTE -1.25%
BLU 0.03%
BLUE -4.41%
BMEA -15.26%
BMRN 0.08%
BNOX 4.46%
BNTC -2.95%
BNTX -2.13%
BOLD -11.17%
BOLT 0.33%
BPMC -2.38%
BPTH -4.05%
BPTS -13.47%
BRNS -0.37%
BRTX -5.90%
BTAI 13.53%
BTTX 20.00%
BTX 0.05%
BVXV 0.74%
BXRX 7.39%
BYSI 2.78%
CABA 1.18%
CADL 1.41%
CALA 0.00%
CALC -3.82%
CALT -1.59%
CAPR -0.43%
CARA -11.72%
CARM 6.53%
CASI -1.18%
CATB -6.97%
CBAY 0.03%
CBIO -2.65%
CBLI -7.31%
CBUS 1.45%
CCCC -1.59%
CCXI 0.00%
CDAK 0.00%
CDIO -4.66%
CDIOW 24.00%
CDMO -1.41%
CDMOP 0.04%
CDT -5.69%
CDTTW -39.60%
CDTX -6.36%
CDXC 9.63%
CDXS 9.66%
CELC -3.46%
CELU 0.74%
CELUW 11.80%
CERC -1.68%
CERE -1.76%
CERO -5.02%
CEROW -10.18%
CFRX -27.95%
CGEM 0.12%
CGEN -3.59%
CGON -2.77%
CGTX -3.41%
CHMA -6.00%
CHRS 5.06%
CINC 0.00%
CING -3.90%
CINGW 34.95%
CKPT -0.96%
CLBS -16.75%
CLDX -0.75%
CLGN -0.50%
CLLS -3.11%
CLNN -2.50%
CLNNW 0.00%
CLRB 6.47%
CLSD -2.40%
CLSN -0.68%
CLVS 0.00%
CMMB -2.94%
CMND 2.24%
CMPI 0.00%
CMPX 0.93%
CMRA 0.00%
CMRAW 33.33%
CMRX -4.43%
CNCE 0.00%
CNSP -34.50%
CNST 0.00%
CNTA 0.67%
CNTB -1.50%
CNTX -7.76%
COCP -1.83%
COEPW 32.45%
COGT -2.64%
CORT 3.39%
COYA -2.44%
CPRX -1.39%
CRBP -1.32%
CRBU -7.95%
CRDF 2.43%
CRGX -1.85%
CRIS -2.64%
CRNX -5.97%
CRSP 0.77%
CRTX 2.63%
CRVO -6.30%
CRVS 0.28%
CSBR -0.19%
CTCX 1.20%
CTIC 0.06%
CTMX -3.70%
CTNM 5.57%
CTXR -4.87%
CUE -3.11%
CVAC -4.94%
CVKD -2.34%
CWBR 2.80%
CYAD -12.96%
CYCC 18.13%
CYCCP 5.28%
CYCN 7.81%
CYT -2.27%
CYTK -3.12%
CYTO 0.00%
DARE 0.86%
DAWN -0.15%
DBTX -0.81%
DBVT 4.17%
DFFN 10.28%
DICE 0.06%
DMAC 31.86%
DNLI -1.87%
DNTH -2.20%
DOMH 1.06%
DRMA -2.57%
DRMAW -1.25%
DRNA 0.00%
DRTS 0.46%
DRTSW 0.00%
DRUG -0.10%
DSGN -2.42%
DTIL -0.21%
DYAI 9.68%
EARS -1.77%
EDIT -2.91%
EDSA 4.14%
EFTR 1.50%
EFTRW -51.85%
EIGR -9.21%
ELAB -3.01%
ELDN 7.14%
ELEV -1.24%
ELOX 10.77%
ELTX -3.38%
ELVN -1.49%
ELYM 5.44%
ENGN 0.49%
ENGNW -21.67%
ENLV -1.45%
ENOB 1.79%
ENSC 6.55%
ENTA -0.90%
ENTO -4.97%
ENTX 0.53%
ENVB -0.02%
EPIX -2.68%
EPRX -2.87%
EPZM 0.00%
EQ -1.24%
EQRX -2.09%
EQRXW 0.00%
ERAS 6.25%
ERNA -2.78%
ERYP 1.30%
ESLA 4.30%
ESLAW 16.64%
ETNB -6.23%
ETON 2.44%
ETTX 0.00%
EVAX 0.00%
EVGN 3.46%
EVLO 0.00%
EWTX 0.29%
EXAI -0.42%
EXEL 0.92%
EYEG -0.69%
EYEN 0.00%
EYPT -0.18%
FATE -12.37%
FBIO 0.89%
FBIOP 0.87%
FBLG -10.30%
FBRX -0.04%
FDMT -4.68%
FENC -2.66%
FGEN -10.21%
FHTX 8.59%
FIXX 0.77%
FMTX 0.00%
FNCH 0.00%
FOLD -1.87%
FREQ 4.76%
FRLN 0.15%
FRTX 0.00%
FSTX 0.00%
FTRE 0.89%
FULC 2.34%
FUSN 0.00%
FWBI 4.59%
FWP 0.00%
GALT 0.00%
GANX -1.54%
GBIO -0.71%
GBT 0.01%
GDTC 2.05%
GERN -1.66%
GHRS -4.27%
GLMD -2.48%
GLPG -1.79%
GLSI 10.66%
GLTO -3.86%
GLUE -2.37%
GLYC -15.09%
GMAB -0.37%
GMDA -18.25%
GMTX 0.00%
GNCA -85.71%
GNFT -2.34%
GNLX -3.98%
GNPX -4.41%
GNTA 3.94%
GOSS -7.73%
GOVX -6.75%
GOVXW 10.89%
GPCR -5.46%
GRAY -10.80%
GRCL 0.05%
GRNA -0.03%
GRNAW 8.91%
GRPH -2.75%
GRTS -2.16%
GRTX -1.66%
GTHX 2.27%
GUTS 0.12%
GXGXW 41.67%
GYRE -5.95%
HALO -0.86%
HARP 0.09%
HCWB -3.76%
HEPA -3.50%
HGEN -84.62%
HILS 5.66%
HLVX 0.31%
HOOK 1.19%
HOTH -3.78%
HOWL 0.43%
HRMY 3.16%
HRTX 8.36%
HSTO 0.00%
HUMA 1.93%
HUMAW -6.25%
IBRX -5.64%
ICCC -2.10%
ICPT 0.21%
ICU 20.03%
ICUCW 4.86%
ICVX -0.91%
IDRA -23.04%
IDYA -3.29%
IFRX -3.52%
IGMS -2.12%
IKNA -1.49%
IKT -2.08%
IMAB -0.58%
IMCR -3.40%
IMGN 0.02%
IMGO 0.00%
IMMP 5.51%
IMMX -3.88%
IMNM 3.68%
IMNN 1.77%
IMPL -27.27%
IMRA 15.96%
IMRN -0.40%
IMRX -3.50%
IMTX -1.25%
IMTXW 6.00%
IMUX -5.50%
IMV 0.00%
IMVT -4.08%
INAB -1.12%
INBX -3.11%
INCY -2.11%
INDP 6.88%
INFI -52.38%
INKT 0.00%
INM 3.06%
INMB 2.38%
INO 1.95%
INSM -0.99%
INTS -3.73%
INVA 0.77%
INZY 1.14%
IOBT -7.48%
IONS 1.64%
IOVA -3.91%
IPA 1.08%
IPHA 2.54%
IPSC -2.34%
IRON -1.82%
ISEE 0.38%
ITOS 2.74%
ITRM 1.36%
IVA 6.96%
IVVD 0.41%
JAGX 0.26%
JANX -4.94%
JAZZ -0.69%
JNCE 0.00%
JSPR -1.51%
JSPRW 20.88%
JUNS 0.00%
JUNSW 0.00%
KA -3.49%
KALV -2.60%
KDNY 0.22%
KMPH -0.34%
KNSA -2.58%
KNTE -0.38%
KOD -8.88%
KPRX -5.76%
KPTI -8.86%
KRBP -10.00%
KRON 1.61%
KROS -0.33%
KRRO -1.59%
KRTX 0.03%
KRYS 0.96%
KTRA 9.72%
KTTA -0.65%
KTTAW 0.92%
KURA 0.93%
KYMR -3.56%
KYTX -5.43%
KZIA 6.13%
KZR -1.77%
LABP 0.57%
LBPH 0.64%
LBPS 0.00%
LBPSW 14.81%
LEGN 3.03%
LENZ -3.21%
LEXX 0.58%
LEXXW -14.63%
LGND -0.82%
LGNDV 0.00%
LGVN -9.09%
LIAN -8.28%
LIFE 2.70%
LIPO -5.29%
LIXT -9.76%
LIXTW 46.21%
LJPC -0.32%
LMNL 0.12%
LOGC 0.43%
LPCN -4.36%
LPTX -1.10%
LQDA 0.24%
LRMR -0.43%
LSTA -1.68%
LTRN 5.49%
LUMO 0.67%
LVTX -5.10%
LXEO -12.98%
LXRX -0.88%
LYEL -35.87%
LYRA 4.19%
MACK 0.10%
MBIO -11.90%
MBRX -1.43%
MCRB 0.80%
MDGL -1.87%
MDNA -13.16%
MDWD 3.78%
MDXG -1.55%
MEIP 0.70%
MESO -1.48%
MGNX -5.24%
MGTA -7.74%
MGTX -0.12%
MGX -0.54%
MIRM -0.42%
MIRO 0.59%
MIST 1.92%
MITO 0.00%
MLEC -6.54%
MLECW 2.31%
MLND -5.36%
MLTX 0.88%
MLYS -8.42%
MNKD -0.67%
MNMD 2.83%
MNOV 1.41%
MNPR -9.34%
MOLN 0.76%
MOR 0.62%
MORF -2.76%
MREO 0.14%
MRKR -0.43%
MRNA -10.77%
MRNS -6.59%
MRSN -3.57%
MRTX -0.17%
MRUS 0.67%
MRVI 1.46%
MTCR -1.29%
MTEM 7.43%
MTP -18.50%
MURA -4.36%
MYMD 2.17%
NAMS -0.15%
NAMSW 0.64%
NAUT 1.11%
NBRV 0.71%
NBSE -1.56%
NBTX 8.91%
NCNA -0.18%
NERV -0.32%
NEXI 1.50%
NGM -1.28%
NGNE 3.57%
NKGN 10.92%
NKGNW -20.00%
NKTR 1.87%
NKTX -2.69%
NLSP 5.63%
NLSPW 26.67%
NMRA -1.26%
NMTR -42.97%
NOVN -24.84%
NRBO 14.85%
NRIX -1.49%
NRSN 0.78%
NRSNW 0.00%
NRXP -8.92%
NRXPW 18.33%
NRXS -1.20%
NTBL 2.63%
NTEC -12.45%
NTHI 0.00%
NTLA -4.83%
NTRBW -31.07%
NUVL -1.94%
NVAX -5.93%
NVCT -7.75%
NVIV -34.28%
NXTC -6.71%
NYMX -0.05%
OABI 3.04%
OABIW -10.06%
OBIO 0.00%
OBSV 0.00%
OCEA -4.23%
OCGN 7.66%
OCS -1.00%
OCUL 0.69%
OCUP 0.00%
ODT -4.27%
OKYO 1.72%
OLMA -4.68%
OMER -2.57%
OMGA -2.08%
ONCO 6.16%
ONCR -3.08%
ONCS 31.87%
ONCT -2.04%
ONCY 2.90%
ONTX -0.47%
ONVO 1.01%
OPNT 0.00%
OPT -5.15%
ORGS -0.69%
ORIC -3.56%
ORMP 16.55%
ORPH 0.00%
ORTX 0.30%
OSMT -1.77%
OTIC -92.64%
OTLK -0.28%
OVID 0.40%
OYST 0.00%
PALI -0.48%
PASG 0.00%
PBLA -7.50%
PBM -4.75%
PBYI 4.39%
PCSA 0.95%
PCVX 0.56%
PDSB -4.75%
PEPG 1.31%
PGEN -6.39%
PHAR 1.99%
PHAS 0.00%
PHAT 0.00%
PHIO -3.55%
PHIOW 36.47%
PHVS -6.50%
PHXM -5.20%
PIRS 0.11%
PKBO 0.00%
PKBOW 999 900.00%
PLRX -2.56%
PLUR 10.34%
PMN -5.55%
PMVP -1.19%
PNT 0.16%
PPBT 1.64%
PRAX 4.86%
PRDS 0.93%
PRLD -3.43%
PROG -3.47%
PROK 2.01%
PRQR 1.20%
PRTA -3.66%
PRTC 0.49%
PRTG 1.40%
PRTK 1.83%
PRVB 0.00%
PSTI -2.91%
PSTV -12.20%
PSTX -4.26%
PTCT -0.03%
PTE -0.82%
PTGX 0.88%
PTIXW -48.41%
PULM 1.56%
PXMD 4.76%
PYPD 1.71%
PYXS 4.58%
QLGN -5.84%
QNCX 2.23%
QNRX 0.84%
QSI -29.12%
QSIAW -9.44%
QTTB 3.66%
QURE -1.35%
RAIN -1.63%
RANI 4.28%
RAPT -1.79%
RARE 1.91%
RCKT -10.31%
REGN -0.26%
RENB -3.42%
REPL -2.43%
RETA 0.02%
REUN -0.89%
REVB -1.40%
REVBU 3.46%
REVBW 5.00%
RGLS -5.61%
RGNX -6.25%
RIGL -6.24%
RLAY -5.71%
RLMD -0.33%
RLYB -5.37%
RNA 2.45%
RNAC 2.69%
RNAZ -1.92%
RNXT 2.23%
ROIV -2.26%
ROIVW 4.56%
RPHM -2.17%
RPRX -0.80%
RPTX -1.46%
RUBY 2.70%
RVLP -32.05%
RVMD -0.55%
RVMDW -29.90%
RVNC -0.43%
RVPH -0.40%
RVPHW -5.28%
RXDX 0.09%
RXRX -6.08%
RYTM -5.68%
RYZB 0.02%
RZLT 3.10%
SABS -1.37%
SABSW -5.53%
SAGE -0.28%
SANA -2.31%
SAVA -4.17%
SAVAW 0.00%
SBBP 1.52%
SBTX 1.03%
SCNI 1.29%
SCPH 11.62%
SCPS 0.00%
SEEL -3.18%
SEER 0.30%
SELB -8.00%
SESN 7.29%
SGEN -0.07%
SGMO -5.00%
SGMT -4.83%
SGTX -2.56%
SIOX 22.63%
SLDB -2.41%
SLGL 5.23%
SLN -8.77%
SLNO 0.98%
SLRX 0.40%
SLS -3.85%
SMMT -3.50%
SNDX 2.46%
SNGX 3.40%
SNPX -2.77%
SONN -1.59%
SPPI -0.49%
SPRB -1.63%
SPRC -3.29%
SPRO 0.38%
SRNE 0.00%
SRPT -0.75%
SRRA 0.00%
SRRK -1.99%
SRZN -2.45%
STAB 0.00%
STOK -7.10%
STRO -1.51%
STSA 0.00%
STTK 7.03%
SURF -0.93%
SVRA -4.35%
SWTX 0.49%
SYBX 0.00%
SYRS -2.07%
TALS -0.73%
TARA -7.62%
TARS -2.13%
TBPH 0.18%
TCBP 5.49%
TCDA 0.00%
TCON -0.70%
TCRR 0.00%
TCRT 4.49%
TCRX -2.58%
TECH -1.20%
TENX -0.32%
TERN -6.76%
TFFP -11.17%
TGTX -7.87%
THRX 0.12%
TIL -1.22%
TLC 0.00%
TLSA -4.65%
TNGX -3.57%
TNXP -9.96%
TNYA -6.48%
TPST 5.10%
TRDA -4.77%
TRVI 1.92%
TRVN 3.15%
TSHA -17.22%
TSVT -4.20%
TTNP -6.05%
TVTX 3.71%
TYRA -7.54%
UBX -2.73%
UNCY -4.00%
URGN 3.82%
UTHR -0.42%
VACC 11.36%
VALN -3.15%
VAXX 118.75%
VBIV -0.79%
VBLT -8.77%
VCEL 1.65%
VCNX 9.30%
VCYT -0.97%
VERA -4.48%
VERU 1.45%
VERV -3.54%
VIGL 0.81%
VINC 2.81%
VIR -1.03%
VIRI -5.66%
VIRX 3.47%
VKTX -0.94%
VLON -13.04%
VNDA -3.10%
VOR -6.07%
VRCA 0.85%
VRDN -3.13%
VRNA -1.66%
VRPX 3.58%
VRTX -0.16%
VSTM 4.76%
VTGN -2.26%
VTVT 1.28%
VTYX -1.67%
VXRT -0.49%
VYGR -0.64%
VYNE -5.80%
VYNT 7.78%
WINT -2.72%
WVE -8.69%
XBIO 1.03%
XBIT 4.17%
XCUR 0.23%
XENE -0.92%
XERS 4.76%
XFOR 5.73%
XLO 3.06%
XLRN 0.00%
XNCR 0.31%
XOMA -8.36%
XOMAO -0.45%
XOMAP -0.82%
XRTX -7.96%
YMAB -1.55%
ZGNX 0.00%
ZIOP -0.88%
ZLAB -2.73%
ZNTL -1.07%
ZSAN 0.00%
Insider Trading
Date Person Action Amount type
2024-06-06 Weis Holger Buy 19 200 Employee Stock Option (right to buy)
2024-06-06 Weis Holger Buy 4 524 Employee Stock Option (right to buy)
2024-06-06 Vieser Jaime Buy 12 800 Employee Stock Option (right to buy)
2024-06-06 Postma Robert W Buy 12 800 Employee Stock Option (right to buy)
2024-06-06 Hofmeister Robert Buy 12 800 Employee Stock Option (right to buy)
INSIDER POWER
96.63
Last 87 transactions
Buy: 15 616 124 | Sell: 1 296 896
Korrelasjon (AI algo v.1.1b): Undervalued: 0.35% $0.694 paired level. (Algoen sporer endringene til de mest korrelerte aksjene i sanntid og gir umiddelbar oppdatering)

Alaunos Therapeutics, Korrelasjon

10 Mest positive korrelasjoner
OMEX0.832
10 Mest negative korrelasjoner

Visste du det?

Korrelasjon er en statistisk måling som beskriver forholdet mellom to variabler. Den varierer fra -1 til 1, hvor -1 indikerer en perfekt negativ korrelasjon (hvor en variabel øker, går den andre ned), 1 indikerer en perfekt positiv korrelasjon (hvor en variabel øker, går den andre også opp), og 0 indikerer ingen korrelasjon (det er ingen forhold mellom variablene).

Korrelasjon kan brukes til å analysere forholdet mellom to variabler, ikke bare aksjer. Det er vanligvis brukt innen områder som finans, økonomi, psykologi, og mer.

Alaunos Therapeutics, Økonomi

Annual 2023
Omsetning: $5 000.00
Bruttogevinst: $-2.31M (-46 200.00 %)
EPS: $-2.20
FY 2023
Omsetning: $5 000.00
Bruttogevinst: $-2.31M (-46 200.00 %)
EPS: $-2.20
FY 2022
Omsetning: $2.92M
Bruttogevinst: $163 000 (5.58 %)
EPS: $-2.60
FY 2021
Omsetning: $0.00
Bruttogevinst: $0.00 (0.00 %)
EPS: $-0.370

Financial Reports:

No articles found.

Alaunos Therapeutics, Options Data

Calls

Contract Name Last Trade Date (EDT) Strike Last Price Bid Ask Change % Change Volume Open Interest Implied Volatility Strike Date
No data available

Puts

Contract Name Last Trade Date (EDT) Strike Last Price Bid Ask Change % Change Volume Open Interest Implied Volatility Strike Date
No data available

Alaunos Therapeutics,

Alaunos Therapeutics, Inc., a clinical-stage oncology-focused cell therapy company, develops adoptive TCR engineered T-cell therapies. It develops TCR Library, which is in Phase I/II clinical trial for ten TCRs reactive to mutated KRAS, TP53, and EGFR from its TCR library for the treatment of non-small cell lung, colorectal, endometrial, pancreatic, ovarian, and bile duct cancers; hunTR, a human neoantigen T-cell receptor platform; and mbIL-15 to treat solid tumors. Alaunos Therapeutics, Inc. has a license agreement with PGEN Therapeutics, Inc.; research and development agreement with The University of Texas MD Anderson Cancer Center; and a patent license agreement, and research and development agreement with the National Cancer Institute. The company was formerly known as ZIOPHARM Oncology, Inc. and changed its name to Alaunos Therapeutics, Inc. in January 2022. Alaunos Therapeutics, Inc. is headquartered in Houston, Texas.

Om Live Signaler

Live Trading signaler pa denne siden er ment til å hjelpe deg i beslutningsprossessen for når du bør KJØPE eller SELGE NA. Signalene har opp mot 1-minutt forsinkelse; som med alle andre indikatorer og signaler, er det en viss sjanse for feil eller feilkalkuleringer.

Live signalene er kun veiledende, og getagraph.com tar ikke noen form for ansvar basert pa handlinger gjort på disse signalene som beskrevet i Terms of Use. Signalene er basert på en rekke indikatorer og påliteligheten vil variere sterke fra aksje til aksje.

Total Execution Time: 2.3529679775238 seconds
Number of API calls: 3
Number of DB calls: 9